Emory University announced on Monday that it had created a committee to evaluate how it handles potential conflicts of interest among its researchers.

The move followed recent revelations that Charles B. Nemeroff, an eminent psychiatrist at the university, accepted $2.5-million in payments from pharmaceutical companies from 2000 to 2007 but disclosed only about half that amount to the university, a violation of university and federal policies that has drawn the attention of Senate investigators.

James W. Wagner, president of Emory, established the Advisory Commission on Research Integrity and Professional Conflict Management to “evaluate the completeness and appropriateness of our policies, the effectiveness of our practices, and the mettle of our culture concerning financial and professional conflicts of interest,” he said in a written statement. The committee will be led by Paul R. Wolpe, who directs Emory’s Center for Ethics.

The university is investigating Dr. Nemeroff, who has stepped down from his post as head of the psychiatry department. In August, the National Institutes of Health froze a $9.3-million grant to a team led by Dr. Nemeroff to study depression. He has since been removed as chief scientist on that project. —Richard Monastersky